VIE/PTPN (VIE/PTPN)

Vienna Stock Exchange: VIE/PTPN · EUR

€1.66

-0.04 (-2.1%)· Recorded snapshot

Market cap	41.5M
Revenue (ttm)	242K
Net income (ttm)	-15M
EPS (ttm)	-€0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 242K
Net income (ttm): -15M
EPS (ttm): -€0.61
Market cap: 41.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-43.3

P25 4.8P50 10.6P75 20.1

ROIC-32

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/PTPN indicators

Market & fundamental data

Available fields

141

Groups with data

Currency

EUR

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-12
Employees	38
Employees change	-32
Employees growth	-45.71%
Enterprise value	EUR 37.9M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2019
Industry	Biotechnology
Is primary listing	No
ISIN number	DE000A40AEG0
Last earnings date	2026-08-06
Last refreshed	2026-10-30
Market cap	EUR 41.5M
Next earnings date	2026-11-12
Price	EUR 1.66
Price currency	EUR
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-29
Symbol	vie/PTPN
Website	https://www.pentixapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-36.77%
EV/Sales	156.68x
FCF / EV yield	-38.55%
FCF yield	-35.21%
P/B ratio	1.46x
P/S ratio	171.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-7,356.61%
Pretax margin	-7,362.4%
Profit per employee	EUR -395,579
Revenue per employee	EUR 6,368
ROA	-24.84%
ROCE	-50.15%
ROE	-43.27%
ROIC	-32.03%
Tax / revenue	-1,150.83%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue growth	-86.48%
Revenue growth (Q)	-91.18%
Revenue growth (QoQ)	-74.58%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -19,000
Depreciation and amortization	EUR 222,000
EBIT	EUR -17.8M
EBITDA	EUR -17.6M
EPS	EUR -0.61
Financing cash flow	EUR 4M
Free cash flow	EUR -14.6M
Gross profit	EUR -5.2M
Income taxes	EUR -2.8M
Investing cash flow	EUR -19,000
Net borrowing	EUR 4M
Net cash flow	EUR -10.6M
Net income	EUR -15M
Operating income	EUR -17.8M
Revenue	EUR 242,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.06
Book value per share	EUR 1.15
Debt / equity	0
Interest coverage	-204.63
Long-term assets	EUR 33.8M
Long-term liabilities	EUR 7M
Net cash (debt)	EUR 3.6M
Net cash / market cap	8.66%
Net cash growth	-74.7%
Net debt / equity	-0.13
Piotroski F-Score	1
Property, plant and equipment	EUR 16,000
Shareholders' equity	EUR 28.5M
Tangible book value	EUR -2M
Tangible book value per share	EUR -0.08
Total assets	EUR 38.5M
Total cash	EUR 3.6M
Total debt	EUR 0
Total liabilities	EUR 10M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.01
Current assets	EUR 4.7M
Current liabilities	EUR 3M
Current ratio	1.55
Net working capital	EUR -1.9M
Quick ratio	1.26
Working capital	EUR 1.7M
Working capital turnover	0.04

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 2.04
1D price change	-2.06%
1M price change	-10.99%
1M total return	-10.99%
1W price change	-7.78%
1W total return	-7.78%
1Y price change	0.36%
1Y return CAGR	6.55%
1Y total return	6.55%
20-day SMA	EUR 1.82
200-day SMA	EUR 2.02
3M price change	-16.58%
3M total return	-16.58%
50-day SMA	EUR 1.85
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 3.55
52-week high date	2026-02-20
52-week low	EUR 1.33
52-week low date	2025-11-11
6M price change	-20.19%
6M total return	-15.28%
All-time high	EUR 3.55
All-time high date	2026-02-20
All-time low	EUR 1.33
All-time low date	2025-11-11
Average true range (ATR)	EUR 0.03
Average volume	0
Change from 52-week high	-53.24%
Change from 52-week low	24.81%
Change from all-time high	-53.24%
Change from all-time low	24.81%
Change from open	0%
Day's gap	-2.06%
High price	EUR 1.66
Low price	EUR 1.66
Monthly RSI	37.36
Open price	EUR 1.66
Previous close	EUR 1.70
Price vs 150-day SMA	-18.43%
Price vs 20-day SMA	-8.89%
Price vs 200-day SMA	-17.94%
Price vs 50-day SMA	-10.27%
Relative volume	7.74
RSI	17.91
Sharpe ratio	0.36
Sortino ratio	0.81
Weekly RSI	32.2
YTD price change	13.86%
YTD total return	20.87%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18.1M
Shares change (QoQ)	0%
Shares held by insiders	0.2%
Shares held by institutions	3.69%

Deeper analysis on VIE/PTPN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/PTPN report

Is a complete VIE/PTPN research report available?

No complete published report is available for vie/PTPN (VIE/PTPN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/PTPN (VIE/PTPN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/PTPN

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/PTPN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on VIE/PTPN

Frequently asked questions